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Tissue-cultured fibroblasts suspended in a collagen 
matrix actively reduce the size of that matrix by the 
process called lattice contraction. Cultured human fibro-
blasts derived from patients with epidermolysis bullosa 
dystrophica recessive (EBdr) cannot elongate and 
spread out when incorporated in a collagen matrix and 
they are therefore poor at contracting that collagen 
lattice. Culture medium from EBdr fibroblast-populated 
collagen lattice (FPCL) shows an increased concentra-
tion of prostaglandin, PGE2 , compared with that in lat-
tices made with equal numbers of normal human fibro-
blasts. The addition of the nonsteroid anti-inflammatory 
drug, indomethacin, to EBdr FPCL inhibits PGE syn-
thesis, and promotes both cell elongation and spreading, 
as well as lattice contraction. However, the addition of 
indomethacin to normal FPCL does not stimulate either 
the spreading and elongation of cells or lattice contrac-
tion. PGE1 or PGE2 added to normal FPCL inhibits 
lattice contraction and cell elongation and spreading. 
Accordingly, EBdr FPCL does not undergo contraction 
due to altered elongation and spreading of fibroblasts, 
which process is related to enhanced PGE synthesis. It 
is proposed then that the contractile forces responsible 
for lattice contraction are identical to those responsible 
for the spreading and elongation of cells. Characteristic 
of EBdr fibroblasts are elevated levels of PGE2 which 
result in the failure of cells to spread and elongate within 
a collagen matrix. PGE2-treated normal cells do not 
readily spread and elongate and they do not readily 
contract FPCL. 
The inherited disease epidermolysis bullosa dystrophica re-
cessive (EBdr) is clinically characterized by minor trauma 
inducing blister formation in the skin and mucosal surfaces 
[1]. Anatomically, blistering occurs below the basement mem-
brane plane within the papillary dermal layer. Collagen fibril 
structure within the affected papillary dermis shows breakdown 
and focal destruction [2]. Cultured fibroblasts from patients 
with EBdr show increased synthesis and secretion of mamma-
lian collagenase [3,4]. In addition to increased collagenase 
activity, the collagenase appears to be structurally altered, 
having lower thermal stabili ty and diminished affinity for its 
metal cofactor calcium [5-7]. 
Monolayer cu ltures of EBdr fibrob lasts show altered growth 
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patterns on plastic surfaces. EBdr fibroblasts tend to grow over 
their neighbors at angles close to go• (8). Cultured EBdr fibro-
blasts entrapped within a collagen matrix show a stellate mor-
phology when examined by phase contrast optics (8). By con-
trast, normal human fibroblasts surrounded by a collagen ma-
trix acquire an elongated, f1attened, spread-out appearance [8, 
9]. Within 24 h these human fibroblasts incorporated in a 
collagen lattice reduce t he size of t hat latt ice in t he process 
referred to as lattice contraction (9) . When EBdr fibroblasts 
are entrapped within a collagen lattice there appears to be a 
relationship between their reduced abili ty to elongate and 
spread out and their reduced ability to contract that lattice. 
Synovial cells isolated from rheumatic arthritis joints pro-
duce excess amounts of collagenase and prostaglandins [10). 
These synovial cells are fibroblast-like cells which have a 
stellate-like morphology associated with the production of col-
lagenase and PGE2 [11,12). Since EBdr fibroblasts produce 
excess amounts of collagenase, the possibility that they also 
produce excess amounts of PGE2 is investigated. Increased 
amounts of PGE2 can alter fibroblast morphology in monolayer 
culture [13]. The promotion of prostaglandin synthesis by 
macrophage-derived factor(s) alters the morphology of normal 
human fibroblasts incorporated into fibroblast-populated col-
lagen lattice (FPCL) (14). In this study, EBdr fibroblasts within 
FPCL are examined for increased synthesis of PGEz. The 
effects of adding PGE2 to normal human fibroblasts on lattice 
contraction and cellular morphology is also studied. Addition-
ally, the effects of the inhibition of PGE production by non-
steroid anti-inf1ammatory drugs (NSAI) on EBdr FPCL is 
presented. 
MATERIALS AND METHODS 
Collagen used in these studies was pepsin extracted from the benign 
neoplasm leiomyoma discarded after pathology samplings fo llowing 
surgical removal at the Massachusetts General Hospital. Briefly, leio-
myoma were frozen and powdered in Spex Freezing Mill (Metuchen, 
New Jersey) . Fresh powdered tissue was taken up in 0.5 M acetic acid 
with 0.1 % pepsin, stirred at 2"C for 48 h, t hen centrifuged at 10.000 g 
for 10 min and t he collagen-r ich supernatant saved. The supernatant 
was neutralized with 2M NaOH, and sodium chloride was added to the 
final concentration of 20% w/v. The mixture was stirred overnight at 
2"C, centrifuged at 10,000 g for 15 min, and the pellet saved. The pellet 
was then resuspended in 0.1 M acetic acid. Following exhaustive dialysis 
against 1 mM HCl, the collagen solution was cleared by centrifugation 
at 10,000 g for 30 min. The supernatant was then frozen, lyophilized, 
weighed, and taken up in sterile 1 mM HCl at 5 mg/ml and stored in a 
sterile bottle. This collagen soluti'on was kept at 4 ·c until needed. 
The culture medium used for all experiments described was Dulbec-
co's modification of Eagle's medium containing 20% v/v feta l bovine 
serum and 25 !lg/ml gentamicin . The fibroblasts for these experiments 
were described previously [8]. The EBdr cell lines used were REBD, a 
gift from Dr. H. P. Baden, Dermatology Services, Massachusetts Gen-
eral Hospital , and 3592, a gift from Dr. A. Mulunsky, Boston University 
Medical Center. ln addition, Dr. Mulunsky supplied cell line 3358 
which is a fib roblast cell line obtained from one of the parents of 3592. 
Dr. R. W. Erbe, Pediatrics Department, Massachusetts General Hos-
pital, supplied normal MGH-287 fibroblasts, which are age matched to 
the REBD cell line. 
FPCL were manufactured by rapidly mixing together 1 ml of culture 
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medium in a 35-mm bacteriologic Petri dish with 0.5 ml fibroblasts 
suspended in the same medium and 0.5 ml of the cold collagen solution. 
In less than 2 min at 37"C in 5% C02 and 95% air atmosphere the 
collagen polymerizes, trapping fibroblasts within a polymerized colla-
gen matrix. Agents were added to the Petri dish during the mixing of 
cells, medium, and collagen. 
Indomethacin (Sigma, St. Louis, Missouri) was added to make a 
final concentration of 10 !Lg/ml. PGE, and PGE2 (Upjohn, Kalamazoo, 
Michigan) , were added to make 10-6-10-10 M final concentration. 
At 48 h, the lattice area was recorded directly by measuring the 
diameter of the FPCL to the nearest 0.5 mm. Fibroblast morphology 
was documented with a Zeiss IM35 inverted microscope with Nomarski 
differential interference contrast optics. With this optical system no 
plastic material may be in the light path; therefore, pie-shape wedges 
were cut from a lattice and transferred to a glass coverslip. Specimens 
were covered with a glass microscope slide and then examined. All 
photographs were taken with Kodak Panatomic X 35-mm film. 
PGE2 concentrations from 48-h-old FPCL culture medium were 
measured by a radioimmunoassay kit purchased from Seragen (Boston, 
Massachusetts) . Instructions furnished with the kit were rel iable and 
reproducible. An analysis of radioimmunoassay results used a published 
log-logit procedure applicable to a hand-held calculator [15]. Data were 
statistically averaged using a non-paired Student's t-test. 
RESULTS 
FPCL with incorporated normal human fibroblasts (70,000 
cells/latt ice), reduce the size of that lattice from 800 mm2 to 
113 mm2 in 48 h (see Table I). By contrast, FPCL made with 
EBdr fibroblast cell line 3592 (70,000 cells/ lattice) are less able 
to contract t he coll agen lattice, and at 48 h an 800 mm 2 lattice 
area is reduced to only 283 mm2• Decreasing t he number of 
cells initially incorporated into FPCL reduced the amount of 
contraction observed at 48 h. When 25,000 normal human 
fibroblasts were incorporated in to an FPCL at 48 h, the lattice 
area had been reduced from 800 mm2 to 314 mm2 , while an 
FPCL populated with 25,000 EBdr fibroblasts showed no con-
traction at 48 h. Therefore equa l numbers of affected fibroblasts 
were less capable of contracting FPCL than normal human 
fibroblasts. 
The concentrations of PGE2 in 48-h -old FPCL were meas-
ured in culture medium from either normal human fibroblasts 
or EBdr fibroblasts. Released PGE2 accumulated in the cu lture 
medium from these different populated collagen latt ices. In 
Table I, experiment #3, 65,000 normal human fibroblasts con-
tract an FPCL to an area of 113 mm at 48 h, producing a 
concentration of PGE2 at 10.8 ± 5.0 ng/0.1 ml of medium. In 
comparison EBdr fibrob lasts within an FPCL at 75,000 cells/ 
lattice contracted that lattice to an average of 403 mm2 at 48 h 
and had elevated concentrations of PGE2 at 149 ± 16 ng/0.1 
mi. The addit ion of indomethacin at 10 !Lg/ml to a normal 
FPCL has no effect upon contraction at 48 h, but it served to 
reduce PGE2 accumulation in the medium to 0.85 ± 0.2 ng/0.1 
ml medium. Indomethacin added to EBdr FPCL promoted 
lattice contraction where lattices contracted to 201 mm2 at 48 
h and PGE2 concentrations were lowered to 4.32 ± 1.4 ng/0.1 
ml of medium (Table I, experiment #3). Therefore, EBdr FPCL 
not only produce and secrete increased amounts of PGE2 but 
t hey also show retarded lattice contraction. The inhibition of 
EBdr PGE2 synthesis with indomethacin decreased medium 
PGE2 concentration and promoted lattice contraction. 
Adding either PGE, or PGE2 to normal FPCL inhibited 
FPCL contraction. This inhibition of contraction was dose-
dependent (Table I, experiment #2). However, adding PGE2 at 
10-6 M to an EBdr FPCL had only a small inhibitory effect on 
lattice contraction (Table I, experiment #5). It appears that the 
high endogenous levels ofPGE were close to maximal for lattice 
contraction inhibition. Adding PGE2 to a normal FPCL at w-6 
M inhibited lattice contraction (Table I, experiment #4). Adding 
both indomethacin and PGE2 to a normal FPCL produced 
inhibition to contractio n. T his would be expected since indo-
methacin blocks PGE2 synthesis by binding to the enzyme 
cyclooxygenase. It does not alter the biologic action of PGE, it 
only blocks the synthesis of PGE. 
In previous work reported from this laboratory, EBdr fibro-
blasts entrapped within a collagen lattice did not spread out or 
elongate as well as normal fibroblasts [8]. Using Nomarski 
optics with an inverted microscope, normal fibroblast spreading 
can be compared to EBdr fibroblasts. Differences between 
normal and affected cells are readily demonstrated at 24 h (Fig 
1A,B). The manufacture of EBdr collagen lattice with added 
indomethacin at 10 !Lg/ml not on ly promoted lattice contraction 
as shown in Table I, experiment #3, but promoted cellular 
spreading and elongation (Fig 1C). Indomethacin blockerl pros-
taglandin synthesis, promoted lattice contraction, and caused 
cell elongation and spreading. 
TABLE r. Normal and EBdr fibroblasts incorporated into a. collagen lattice for 48 hours 
Experiment 
1. Untreated 
Untreated 
2. Untreated 
PGE, 10-6 M 
PGE, 10-6 M 
PGE, 10- 10 M 
3. Untreated 
Indomethacin 
10 !Lg/ml 
Untreated 
Indomethacin 
10 !lg/ml 
4. PGE. 10-6 M 
PGE2 10-6M + indomethacin 
10 !lg/ml 
Untreated 
Indomethacin 
10 !lg/ ml 
5. PGE2 10-6 M 
Untreated 
• Normal human fibroblast (NHF) cell line 3358. 
**Normal human fibroblast (NHF) celllir1e 287. 
t EBdr cell line 3592. 
H EBdr cell line REBD. 
"Statistically significant, p ,;; 0.01. 
b Statistically sign ificant, p ,;; 0.05. 
Cell type 
in FPCL 
NHF* 
EBdr* 
NHF* 
NHF** 
NHF** 
EBdrt 
EBdrt 
NHF** 
NHF** 
NHF** 
NHF** 
EBdrtt 
EBdrtt 
Lattice area Cell PGE in medium (mm' ) number (ng/0.1 ml) 
113 70K 
283 70K 
132 60K 
254 60K 
226 60K 
132 60K 
113 65K 10.8 ± 5.0" 
113 651( 0.85 ± 0.2 
403 75K 149 ± 66"·6 
201 75K 4.32 ± 1.46 
314 40K 
314 40K 
176 40K 
176 40K 
363 70K 
346 70K 
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T he addition of E series prostaglandin to norma l FPCL was 
examined at 24 h. When eit her PGE, or PGE2 was added at 
w-G M, lattice contraction was inhibi ted (Table I, experiments 
#2 and #4). Addition of PGE also inhibi ted ce ll spreading a nd 
elongation as shown in Fig 1D and E. Increased concent rations 
of series E prostaglandins in FPCL inhibits cell e longation and 
spreading, which appears to impair lattice con traction . 
DISCUSSION 
F ibrob lasts derived from affected individua ls wit h EBdr are 
morp hologically and functiona lly different from t hose fibro-
blasts derived from normal individuals. W hen incorporated in to 
an FPCL, affected individual fibrob lasts do not sp read out and 
elongate, nor do t hey contract lattices as efficiently as normal 
fibroblasts [8]. The alteration of the fibrob last morpho logy and 
its inabili ty to contract t he collage n lattice has been docu-
mented in transfo rmed ce lls within FPCL [16]. The addition 
of a soluble factor( s) synthesized and secreted by activated 
monocytes also alters t he morphology of t he fibrob last, result-
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FIG 1. Normal and EBdr fibroblast morphology within FPCL. 
FPCL were made with 50,000-70,000 fibroblasts with either normal or 
affected 3592 cell line and photographed with a Zeiss IM35 inverted 
microscope equipped wi th Nomarski optics. All lattices were examined 
24 h after manufacture. A, Normal human fibroblasts within F'PCL 
showihgelongated cell. B, EBdr fibrob lasts within FPCL. Note rounded 
dendritic- like mo rphology. C, EBdr fibroblasts treated with indometh-
acin at the time of lattice manufacture. Note cells are spread out and 
elongated similar to normal fibroblasts. D, A normal human fibroblast 
wi th added PGE, at 10- 6 M . Note cell no longer has a spread-out, 
elongated appea rance and is more dendritic-like and rounded. E, Nor-
mal FPCL containing 10-6 M PGE2 representi t ive fibroblast, does not 
elongate and spread out li ke untreated control. Bars= 10 ,.,m. 
ing in reta rded lattice con t raction. It appears t hat cell shape 
and lattice cont raction a re related. 
EBdr fibroblasts synthesize and secrete more PGE" t han do 
normal fibrob lasts when res iding wit hin a n FPCL. Medium 
from 48-h-old EBdr FPCL has a 13-fold increase in PGE2 
concentration compared with t hat from normal FPCL. By 
adding indomethacin to EBdr FPCL, PGE synt hesis is inhib-
ited, presumab ly by blocking cyclooxygenase. T his enzyme 
complex is t he ini t ia l step in convert ing arachadonic ac id to 
p rostaglandins, p rostacycl in , or t hromboxane [17]. Related to 
inhi bited PGE2 synt hesis, treated EBdr fibroblasts acquire a 
more elongated and spread-out appearance, and latt ice con-
traction approaches that of normal FPCL. T he addi t ion of 
indomethac in to normal FPCL neither alters morphology nor 
promotes contraction, i.e., fibroblasts rema in elongated and 
spread out and lattice contraction is identical to that in un -
t reated cont rols. H owever, t he add ition of indomethacin to 
EBdr FPCL promotes ce ll elongation , spreadin g, a nd improved 
latt ice contraction. 
The addi t ion of PGE2 to normal FPCL inhibits lattice con-
traction, cell elongation, and spreading, while adding PGE a nd 
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indomethacin to an FPCL with normal human fibroblasts 
causes inhibited lattice cont raction and inhibited cell spreading 
and elongation. This is expected and supports t he hypothes is 
that indomethacin blocks EBdr fibroblast P GE synthesis which 
allows cell elongation, spreading, and lattice cont ract ion. In-
domethacin blocks P GE synthesis, but it does not alter PGE 
action. 
Histologic examination of FPCL made with EBdr cells at 2 
days does not show collagen matrix breakdown, which might 
have been expected due to reported elevated collagenase pro-
duction [3]. Collagenase assay of EBdr and normal human 
FPCL medium at 2 days was at the lowest limits of detection 
using our assay system. This low collagenase act ivity in FPCL 
medium may be related to the low number of cells incorporated 
into these lattices. 
Some cells in primary synovial cell cultures are spindle 
shaped. Adding PGE to these cultured cells causes morphologic 
changes which result in the alteration of their spindle shape to 
an astrocyte- like form in dendri t ic-like processes. If PGE is 
removed, these cells return to their spindle-shape morphology 
within 1 h [13]. 
Evidence presented here points to a relationship between 
EBdr fibroblasts producing more PGE2, thereby causing li ttle 
cell spreading and elongation, when incorporated into a colla-
gen matrix. Stopak and Harris proposed that fibroblasts con-
tract a matrix by direct physical pulling, rather than by simple 
contaction of individual ce lls [18]. Fibroblasts do not shorten 
in length like cont racting striated muscle. It is proposed t hat a 
"t raction force" is responsible for contract ion. This is a shearing 
force tangent ial to the cell surface leading to cell spreading and 
elongation. Hence, fibroblasts may contract a collagen lattice 
wit h "traction forces" that are ident ical to those forces which 
promote ce ll elongat ion and spreading. Inhibit ion of these 
t raction forces in the spreading and elongation of fibroblasts 
inhibit lattice cont raction. Fibroblast-generated traction forces 
can disto rt the elastic surface beneath that cell [19) . The 
cont raction of FPCL requires neither cell shortening, gap junc-
tions, nor direct cell -ce ll interactions, the mechanism for non-
muscle cell cont raction proposed by Gabbiani et a! to explain 
fibroblast contraction of open wounds [20] . Observations made 
with FPCL appear to support the Stopak-Harris t raction struc-
tural hypothesis. Lattice contraction apparent ly occurs by t he 
action of individual ce llular fo rces which causes cellular elon-
gation, spreadin g, and lattice cont raction. Fibroblasts appear 
to remain elongated and spread throughout the process of 
latt ice contraction when viewed by phase contrast optics. 
Indomethacin inhibition of P GE synthesis by EBdr fibro -
blasts may have some clinical value. Inhibiting prostaglandin 
synthesis by treating EBdr patients with NSAI may be bene-
ficial. If, however, collagenase or excess collagenase is the major 
cause of bliste ring associated wit h EBdr syndrome, then inhib-
it ing PGE synt hesis might not be benefi cial to the patient 
[12). It has been shown that synovial fibroblasts in t issue 
cul ture can be stimulated to produce excess amounts of colla-
genase and PGE [10] . Inhibition of PGE synthesis by indo-
methacin blocks P GE synthesis, but it does not alter the 
elevated synthesis and secretion of collagenase [12]. If other 
components of the syndrome are not related to collagenase but 
are associated wit h elevated levels of prostaglandins, then NSAI 
therapy may be advised. 
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